Pernix Therapeutics (NASDAQ: PTX) announced the successful completion of a human pharmacokinetic equivalence study with ZX007, an innovative abuse deterrent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE